It's done by making a cut in your groin that the testicle is removed through, along with all the tubes and blood vessels attached to the testicle that pass through the groin into the tummy. If testicular cancer is detected in its very early stages, an orchidectomy may be the only treatment you require.Īn orchidectomy is not carried out through the scrotum. You should ask your surgeon about this if you're in this position. In such circumstances, it's sometimes possible to only remove the part of the testicle containing the tumour.
Radiation exposure x ray testicle full#
If you have testicular cancer, the whole of the affected testicle will need to be removed because only removing the tumour may lead to the cancer spreading.īy removing the entire testicle, your chances of making a full recovery are greatly improved. Your sex life and ability to father children will not be affected.Ībout 1 in 50 people will get a second new testicular cancer in their remaining testicle. OrchidectomyĪn orchidectomy is a surgical procedure to remove a testicle. Your cancer team will make recommendations, but the final decision will be yours.īefore discussing your treatment options with your specialist, you may find it useful to write a list of questions to ask them.įor example, you may want to find out the advantages and disadvantages of particular treatments. In non-seminoma germ cell tumours, additional surgery may also be required after chemotherapy to remove tumours from other parts of the body, depending on the extent of the spread of the tumour.ĭeciding what treatment is best for you can be difficult. Some people with stage 2 seminomas may be suitable for less intense treatment with radiotherapy, sometimes with the addition of a simpler form of chemotherapy. The first treatment option for all cases of testicular cancer, whatever the stage, is to surgically remove the affected testicle (an orchidectomy).įor stage 1 seminomas, after the testicle has been removed a single dose of chemotherapy may be given to help prevent the cancer returning.Ī short course of radiotherapy is also sometimes recommended.īut in many cases, the chance of recurrence is low and your doctors may recommend that you're very carefully monitored over the next few years.įurther treatment is usually only needed for the small number of people who have a recurrence.įor stage 1 non-seminomas, close follow-up (surveillance) may also be recommended, or a short course of chemotherapy using a combination of different medications.įor stage 2 and 3 testicular cancers, 3 to 4 cycles of chemotherapy are given using a combination of different medications.įurther surgery is sometimes needed after chemotherapy to remove any affected lymph nodes or deposits in the lungs or, rarely, in the liver. the type of testicular cancer you have – whether it's a seminoma or a non-seminoma.Your recommended treatment plan will depend on: Dose tracking and development of low-dose CT protocols are recommended.Chemotherapy, radiotherapy and surgery are the 3 main treatments for testicular cancer.High CED (>75 mSv) was observed in 77.5 % (93/120) of patients.Median CED in patients with testicular cancer was 125.1 mSv.CT accounted for 98.3 % of CED in patients with testicular cancer.
Radiation exposure x ray testicle software#
Dose management software for accurate real-time monitoring of CED and low-dose CT protocols with maintained image quality should be used by specialist centres for surveillance imaging. Survivors of testicular cancer frequently receive high CED from diagnostic imaging, mainly CT. Surveillance time was associated with high CED (OR 2.1, CI 1.5-2.8). We found that 77.5 % (93/120) of patients received high CED (>75 mSv). Computed tomography accounted for 65.3 % of imaging studies and 98.3 % of CED. Median (IQR) surveillance was 4.37 years (2.0-5.5). In total, 120 patients with a mean age of 30.7 ± 5.2 years at diagnosis had 1,410 radiological investigations. Statistical analysis was performed with SPSS. CED was calculated from DLP using conversion factors. Age at diagnosis, cancer type, dose-length product (DLP), imaging type, and frequency were recorded. Radiological imaging of patients aged 18-39 years, diagnosed with testicular cancer between 20 in two tertiary care centres was examined. This study quantifies CED from diagnostic imaging in these patients. Regular imaging is standard for follow-up. Testicular cancer affects young patients and has a good prognosis. Risks associated with high cumulative effective dose (CED) from radiation are greater when imaging is performed on younger patients.
0 kommentar(er)
